Legal & General Group PLC Axsome Therapeutics, Inc. Transaction History

Legal & General Group PLC

$368 Billion
Q4 2024

A detailed history of Legal & General Group PLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 36,370 shares of AXSM stock, worth $4.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,370

Previous 36,873 1.36%

Holding current value

$4.64 Million

Previous $3.31 Million 7.12%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$83.08 - $100.49 $41,789 - $50,546	-503 Reduced 1.36%	36,370 $3.08 Million
Q3 2024 Feb 28, 2025	SELL	$78.93 - $95.84 $166,305 - $201,934	-2,107 Reduced 5.79%	34,263 $3.08 Million
Q3 2024 Nov 14, 2024	BUY	$78.93 - $95.84 $48,463 - $58,845	614 Added 1.69%	36,873 $3.31 Million
Q2 2024 Aug 14, 2024	BUY	$65.72 - $80.5 $222,922 - $273,056	3,392 Added 10.32%	36,259 $2.92 Million
Q1 2024 May 14, 2024	SELL	$69.39 - $97.64 $10,408 - $14,646	-150 Reduced 0.45%	32,867 $2.62 Million
Q4 2023 Feb 15, 2024	SELL	$57.42 - $83.61 $50,701 - $73,827	-883 Reduced 2.6%	33,017 $2.63 Million
Q3 2023 Nov 14, 2023	BUY	$69.25 - $82.21 $39,888 - $47,352	576 Added 1.73%	33,900 $2.37 Million
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $156,305 - $241,776	2,676 Added 8.73%	33,324 $2.39 Million
Q1 2023 May 15, 2023	BUY	$58.39 - $75.0 $212,364 - $272,775	3,637 Added 13.46%	30,648 $1.89 Million
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $9,985 - $19,930	250 Added 0.93%	27,011 $2.08 Million
Q3 2022 Nov 14, 2022	SELL	$36.06 - $69.85 $63,862 - $123,704	-1,771 Reduced 6.21%	26,761 $1.19 Million
Q2 2022 Aug 22, 2022	BUY	$21.74 - $46.75 $130,157 - $279,892	5,987 Added 26.56%	28,532 $1.09 Million
Q1 2022 May 16, 2022	SELL	$23.7 - $41.39 $331 - $579	-14 Reduced 0.06%	22,545 $933,000
Q4 2021 Feb 14, 2022	BUY	$30.7 - $43.36 $1,842 - $2,601	60 Added 0.27%	22,559 $852,000
Q3 2021 Nov 15, 2021	BUY	$19.91 - $68.26 $94,612 - $324,371	4,752 Added 26.78%	22,499 $741,000
Q2 2021 Aug 12, 2021	SELL	$50.63 - $73.5 $8,404 - $12,201	-166 Reduced 0.93%	17,747 $1.2 Million
Q1 2021 May 17, 2021	BUY	$55.91 - $81.44 $113,553 - $165,404	2,031 Added 12.79%	17,913 $1.01 Million
Q4 2020 Feb 12, 2021	SELL	$66.31 - $86.52 $5,437 - $7,094	-82 Reduced 0.51%	15,882 $1.29 Million
Q3 2020 Nov 13, 2020	SELL	$68.34 - $85.84 $83,374 - $104,724	-1,220 Reduced 7.1%	15,964 $1.14 Million
Q2 2020 Aug 14, 2020	BUY	$49.87 - $98.69 $9,425 - $18,652	189 Added 1.11%	17,184 $1.41 Million
Q1 2020 May 14, 2020	BUY	$41.2 - $101.31 $373,601 - $918,679	9,068 Added 114.39%	16,995 $1 Million
Q4 2019 Feb 13, 2020	BUY	$16.71 - $106.24 $44,966 - $285,891	2,691 Added 51.39%	7,927 $820,000
Q2 2019 Aug 14, 2019	BUY	$13.46 - $25.75 $70,476 - $134,827	5,236 New	5,236 $135,000

Others Institutions Holding AXSM

# of Institutions

351

Shares Held

36.3M

Call Options Held

1.77M

Put Options Held

1.16M

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $5.47B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Axsome Therapeutics, Inc. Transaction History